Published in Mov Disord on June 28, 2012
Deep brain stimulation suppresses pallidal low frequency activity in patients with phasic dystonic movements. Brain (2014) 0.92
Gamma Oscillations in the Hyperkinetic State Detected with Chronic Human Brain Recordings in Parkinson's Disease. J Neurosci (2016) 0.86
Effects of L-dopa priming on cortical high beta and high gamma oscillatory activity in a rodent model of Parkinson's disease. Neurobiol Dis (2015) 0.81
Co-modulation of finely tuned high-gamma band activity across hemispheres in Parkinson's disease. Clin Neurophysiol (2013) 0.77
Systems-level neurophysiological state characteristics for drug evaluation in an animal model of levodopa-induced dyskinesia. J Neurophysiol (2016) 0.75
Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Ann Neurol (2014) 2.33
Initial clinical manifestations of Parkinson's disease: features and pathophysiological mechanisms. Lancet Neurol (2009) 2.28
Novel pharmacological targets for the treatment of Parkinson's disease. Nat Rev Drug Discov (2006) 2.23
Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord (2010) 2.20
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurol (2013) 1.82
Coupling between beta and high-frequency activity in the human subthalamic nucleus may be a pathophysiological mechanism in Parkinson's disease. J Neurosci (2010) 1.81
The subthalamic nucleus is involved in successful inhibition in the stop-signal task: a local field potential study in Parkinson's disease. Exp Neurol (2012) 1.74
Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease. Mov Disord (2008) 1.72
Priorities in Parkinson's disease research. Nat Rev Drug Discov (2011) 1.66
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders. Lancet Neurol (2009) 1.61
Human cerebral activation during steady-state visual-evoked responses. J Neurosci (2003) 1.51
Sound analysis of catathrenia: a vocal expiratory sound. Sleep Breath (2010) 1.48
Reduced noradrenaline, but not dopamine and serotonin in motor thalamus of the MPTP primate: relation to severity of parkinsonism. J Neurochem (2013) 1.43
The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease. Mov Disord (2009) 1.41
Deep brain stimulation: from neurology to psychiatry? Trends Neurosci (2010) 1.28
Late-onset periodic asystolia during vagus nerve stimulation. Epilepsia (2008) 1.27
Independent component analysis as a tool to eliminate artifacts in EEG: a quantitative study. J Clin Neurophysiol (2003) 1.26
Activation of human cerebral and cerebellar cortex by auditory stimulation at 40 Hz. J Neurosci (2002) 1.23
Milestones in research on the pathophysiology of Parkinson's disease. Mov Disord (2011) 1.18
Successful thalamic deep brain stimulation for orthostatic tremor. Mov Disord (2008) 1.17
Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain (2010) 1.15
Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease. Nat Clin Pract Neurol (2006) 1.13
Remote synchronization reveals network symmetries and functional modules. Phys Rev Lett (2013) 1.04
Independent component analysis removing artifacts in ictal recordings. Epilepsia (2004) 1.02
Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease. Neurobiol Dis (2007) 1.01
Changes in the heart rate variability in patients with obstructive sleep apnea and its response to acute CPAP treatment. PLoS One (2012) 0.99
Thalamic innervation of the direct and indirect basal ganglia pathways in the rat: Ipsi- and contralateral projections. J Comp Neurol (2005) 0.97
Reversible generalized dystonia and encephalopathy from thiamine transporter 2 deficiency. Mov Disord (2012) 0.97
Sleep structure in patients with periodic limb movements and obstructive sleep apnea syndrome. J Clin Neurophysiol (2009) 0.97
LRRK2 haplotype-sharing analysis in Parkinson's disease reveals a novel p.S1761R mutation. Mov Disord (2011) 0.97
Time to move beyond nigrostriatal dopamine deficiency in Parkinson's disease. Ann Neurol (2004) 0.95
Alpha and beta oscillatory changes during stimulus-induced movement paradigms: effect of stimulus predictability. Neuroreport (2003) 0.95
Ketamine-induced oscillations in the motor circuit of the rat basal ganglia. PLoS One (2011) 0.95
Progression of dopaminergic depletion in a model of MPTP-induced Parkinsonism in non-human primates. An (18)F-DOPA and (11)C-DTBZ PET study. Neurobiol Dis (2010) 0.94
Functional neuroanatomy of the basal ganglia. Cold Spring Harb Perspect Med (2012) 0.94
Sustained enzymatic correction by rAAV-mediated liver gene therapy protects against induced motor neuropathy in acute porphyria mice. Mol Ther (2010) 0.93
A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys. Neurobiol Dis (2010) 0.89
No Lewy pathology in monkeys with over 10 years of severe MPTP Parkinsonism. Mov Disord (2009) 0.88
Influence of filters in the detrended fluctuation analysis of digital electroencephalographic data. J Neurosci Methods (2008) 0.87
Alpha and beta oscillatory activity during a sequence of two movements. Clin Neurophysiol (2004) 0.87
Orthostatic myoclonus: an underrecognized cause of unsteadiness? Parkinsonism Relat Disord (2013) 0.87
Beta activity in the subthalamic nucleus during sleep in patients with Parkinson's disease. Mov Disord (2009) 0.85
The significance of defining preclinical or prodromal Parkinson's disease. Mov Disord (2012) 0.84
Cognitive and neuropsychiatric effects of subthalamotomy for Parkinson's disease. Parkinsonism Relat Disord (2010) 0.83
Dynamic interaction of spindles and gamma activity during cortical slow oscillations and its modulation by subcortical afferents. PLoS One (2013) 0.83
Short and long term outcome of bilateral pallidal stimulation in chorea-acanthocytosis. PLoS One (2013) 0.83
Delta-mediated cross-frequency coupling organizes oscillatory activity across the rat cortico-basal ganglia network. Front Neural Circuits (2013) 0.83
Abnormal functional connectivity between motor cortex and pedunculopontine nucleus following chronic dopamine depletion. J Neurophysiol (2013) 0.82
Levodopa-induced dyskinesias in the absence of nigrostriatal degeneration. Mov Disord (2013) 0.81
Prevalence of cancer in Parkinson's disease related to R1441G and G2019S mutations in LRRK2. Mov Disord (2013) 0.81
Assessment of a method to determine deep brain stimulation targets using deterministic tractography in a navigation system. Neurosurg Rev (2015) 0.80
Lesion of the centromedian thalamic nucleus in MPTP-treated monkeys. Mov Disord (2008) 0.80
Ascorbate prevents cell death from prolonged exposure to glutamate in an in vitro model of human dopaminergic neurons. J Neurosci Res (2013) 0.79
The mirror system, theory of mind and Parkinson's disease. J Neurol Sci (2011) 0.79
The globus pallidus pars externa and Parkinson's disease. Ready for prime time? Exp Neurol (2006) 0.79
Statistical parametric maps of ¹⁸F-FDG PET and 3-D autoradiography in the rat brain: a cross-validation study. Eur J Nucl Med Mol Imaging (2011) 0.79
Cardiac autonomic impairment during sleep is linked with disease severity in Parkinson's disease. Clin Neurophysiol (2013) 0.79
Coadministration of entacapone with levodopa attenuates the severity of dyskinesias in hemiparkinsonian rats. Mov Disord (2006) 0.79
Inter-hemispheric asymmetry of nigrostriatal dopaminergic lesion: a possible compensatory mechanism in Parkinson's disease. Front Syst Neurosci (2011) 0.78
Basal cardiac autonomic tone is normal in patients with periodic leg movements during sleep. J Neural Transm (Vienna) (2013) 0.78
[Vestibular evoked myogenic potentials and benign paroxysmal positional vertigo]. Acta Otorrinolaringol Esp (2007) 0.78
Cortical oscillations scan using chirp-evoked potentials in 6-hydroxydopamine rat model of Parkinson's disease. Brain Res (2009) 0.77
Levodopa-induced dyskinesias in Parkinson's disease. Handb Clin Neurol (2007) 0.77
Striatal dopamine function in a family with multiple SCA-3 phenotypes. J Neurol (2010) 0.77
Modeling clinical features of neurodegeneration. Nat Med (2010) 0.77
Increased sympathetic and decreased parasympathetic cardiac tone in patients with sleep related alveolar hypoventilation. Sleep (2013) 0.77
Independent component analysis separates spikes of different origin in the EEG. J Clin Neurophysiol (2006) 0.76
Effect of deep brain stimulation of the subthalamic nucleus on non-motor fluctuations in Parkinson's disease: two-years' follow-up. Parkinsonism Relat Disord (2013) 0.76
Oscillatory cortical changes during periodic limb movements. Sleep (2004) 0.76
Pharyngo-laryngoscopic video-recording in obstructive sleep apnea during natural N2 sleep. A case report of a non-complete obstructive mechanism. Sleep Med (2013) 0.75
Node accessibility in cortical networks during motor tasks. Neuroinformatics (2013) 0.75
Oscillatory activity in the human basal ganglia: more than just beta, more than just Parkinson's disease. Exp Neurol (2013) 0.75
Subthalamic role on the generation of spikes in temporal epilepsy. Epilepsy Res (2008) 0.75
Pain and dyskinesia in Parkinson's disease. Mov Disord (2010) 0.75